Skip to main content
SpringerLink
Log in

Genetics of Conotruncal Anomalies

  • Chapter
  • First Online:
Surgery of Conotruncal Anomalies

Abstract

Conotruncal (or outflow tract) defects are among the most common congenital heart diseases found at birth, and are the leading cause of mortality and morbidity in the first year of life. In the last 20 years, the progenitor cells that contribute to cardiac outflow tract development have received much attention. Thus, the role of neural crest and second heart field derivatives has been established during outflow tract development. Particularly, second heart field cells contribute to growth of the outflow tract by addition of cells from the splanchnic pharyngeal mesoderm, whereas neural crest cells populate the endocardial cushions within the outflow tract. It is now well accepted that defective neural crest or second heart field deployment results in a spectrum of conotruncal anomalies ranging from outflow tract alignment to septation defects. In addition, recent studies have improved our understanding of signaling pathways and transcriptional networks required for outflow tract development. In this chapter, we present an overview of cardiac development, with emphasis on the genetic causes of outflow tract anomalies and highlight relevant genetic data for cardiac development in humans as well as animal models.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.

    Article  PubMed  Google Scholar 

  2. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet. 2005;6(11):826–35.

    Article  CAS  PubMed  Google Scholar 

  3. Zaffran S, Kelly RG. New developments in the second heart field. Differentiation Res Biol Divers. 2012;84(1):17–24.

    Article  CAS  Google Scholar 

  4. Kirby ML. Cardiac development. Oxford: Oxford University Press; 2007.

    Google Scholar 

  5. Bajolle F, Zaffran S, Kelly RG, Hadchouel J, Bonnet D, Brown NA, Buckingham ME. Rotation of the myocardial wall of the outflow tract is implicated in the normal positioning of the great arteries. Circ Res. 2006;98(3):421–8.

    Article  CAS  PubMed  Google Scholar 

  6. Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell. 2001;1(3):435–40.

    Article  CAS  PubMed  Google Scholar 

  7. Waldo KL, Kumiski DH, Wallis KT, Stadt HA, Hutson MR, Platt DH, Kirby ML. Conotruncal myocardium arises from a secondary heart field. Development. 2001;128(16):3179–88.

    CAS  PubMed  Google Scholar 

  8. Mjaatvedt CH, Nakaoka T, Moreno-Rodriguez R, Norris RA, Kern MJ, Eisenberg CA, Turner D, Markwald RR. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol. 2001;238(1):97–109.

    Article  CAS  PubMed  Google Scholar 

  9. Ward C, Stadt H, Hutson M, Kirby ML. Ablation of the secondary heart field leads to Tetralogy of Fallot and pulmonary atresia. Dev Biol. 2005;284(1):72–83.

    Article  CAS  PubMed  Google Scholar 

  10. Hutson MR, Zeng XL, Kim AJ, Antoon E, Harward S, Kirby ML. Arterial pole progenitors interpret opposing FGF/BMP signals to proliferate or differentiate. Development. 2010;137(18):3001–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Tirosh-Finkel L, Zeisel A, Brodt-Ivenshitz M, Shamai A, Yao Z, Seger R, Domany E, Tzahor E. BMP-mediated inhibition of FGF signaling promotes cardiomyocyte differentiation of anterior heart field progenitors. Development. 2010;137(18):2989–3000.

    Article  CAS  PubMed  Google Scholar 

  12. Waldo KL, Hutson MR, Ward CC, Zdanowicz M, Stadt HA, Kumiski D, Abu-Issa R, Kirby ML. Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol. 2005;281(1):78–90.

    Article  CAS  PubMed  Google Scholar 

  13. Neeb Z, Lajiness JD, Bolanis E, Conway SJ. Cardiac outflow tract anomalies. Wiley Interdiscip Rev Dev Biol. 2013;2(4):499–530.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yelbuz TM, Waldo KL, Kumiski DH, Stadt HA, Wolfe RR, Leatherbury L, Kirby ML. Shortened outflow tract leads to altered cardiac looping after neural crest ablation. Circulation. 2002;106(4):504–10.

    Article  PubMed  Google Scholar 

  15. Goldmuntz E, Bamford R, Karkera JD, dela Cruz J, Roessler E, Muenke M. CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet. 2002;70(3):776–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424(6947):443–7.

    Article  CAS  PubMed  Google Scholar 

  17. Wei D, Bao H, Liu XY, Zhou N, Wang Q, Li RG, Xu YJ, Yang YQ. GATA5 loss-of-function mutations underlie Tetralogy of Fallot. Int J Med Sci. 2013;10(1):34–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Maitra M, Koenig SN, Srivastava D, Garg V. Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr Res. 2010;68(4):281–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Karkera JD, Lee JS, Roessler E, Banerjee-Basu S, Ouspenskaia MV, Mez J, Goldmuntz E, Bowers P, Towbin J, Belmont JW, Baxevanis AD, Schier AF, Muenke M. Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans. Am J Hum Genet. 2007;81(5):987–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Spinner NB, Colliton RP, Crosnier C, Krantz ID, Hadchouel M, Meunier-Rotival M. Jagged1 mutations in Alagille syndrome. Hum Mutat. 2001;17(1):18–33.

    Article  CAS  PubMed  Google Scholar 

  21. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998;281(5373):108–11.

    Article  CAS  PubMed  Google Scholar 

  22. Ta-Shma A, Pierri CL, Stepensky P, Shaag A, Zenvirt S, Elpeleg O, Rein AJ. Isolated truncus arteriosus associated with a mutation in the plexin-D1 gene. Am J Med Genet A. 2013;161A(12):3115–20.

    Article  PubMed  Google Scholar 

  23. Muncke N, Jung C, Rudiger H, Ulmer H, Roeth R, Hubert A, Goldmuntz E, Driscoll D, Goodship J, Schon K, Rappold G. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation. 2003;108(23):2843–50.

    Article  CAS  PubMed  Google Scholar 

  24. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362(9393):1366–73.

    Article  CAS  PubMed  Google Scholar 

  25. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, Grayzel D, Kroumpouzou E, Traill TA, Leblanc-Straceski J, Renault B, Kucherlapati R, Seidman JG, Seidman CE. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997;15(1):30–5.

    Article  CAS  PubMed  Google Scholar 

  26. Lambrechts D, Devriendt K, Driscoll DA, Goldmuntz E, Gewillig M, Vlietinck R, Collen D, Carmeliet P. Low expression VEGF haplotype increases the risk for Tetralogy of Fallot: a family based association study. J Med Genet. 2005;42(6):519–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Pizzuti A, Sarkozy A, Newton AL, Conti E, Flex E, Digilio MC, Amati F, Gianni D, Tandoi C, Marino B, Crossley M, Dallapiccola B. Mutations of ZFPM2/FOG2 gene in sporadic cases of Tetralogy of Fallot. Hum Mutat. 2003;22(5):372–7.

    Article  CAS  PubMed  Google Scholar 

  28. D'Alessandro LC, Latney BC, Paluru PC, Goldmuntz E. The phenotypic spectrum of ZIC3 mutations includes isolated d-transposition of the great arteries and double outlet right ventricle. Am J Med Genet A. 2013;161A(4):792–802.

    Article  PubMed  Google Scholar 

  29. Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, Elkins R, Dietz HC. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet. 2001;10(2):163–9.

    Article  CAS  PubMed  Google Scholar 

  30. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with Tetralogy of Fallot. Circulation. 2001;104(21):2565–8.

    Article  CAS  PubMed  Google Scholar 

  31. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M, Bitar F. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat. 2006;27(3):293–4.

    Article  PubMed  Google Scholar 

  32. Lin X, Huo Z, Liu X, Zhang Y, Li L, Zhao H, Yan B, Liu Y, Yang Y, Chen YH. A novel GATA6 mutation in patients with Tetralogy of Fallot or atrial septal defect. J Hum Genet. 2010;55(10):662–7.

    Article  CAS  PubMed  Google Scholar 

  33. Baldini A. Dissecting contiguous gene defects: TBX1. Curr Opin Genet Dev. 2005;15(3):279–84.

    Article  CAS  PubMed  Google Scholar 

  34. Griffin HR, Topf A, Glen E, Zweier C, Stuart AG, Parsons J, Peart I, Deanfield J, O'Sullivan J, Rauch A, Scambler P, Burn J, Cordell HJ, Keavney B, Goodship JA. Systematic survey of variants in TBX1 in non-syndromic Tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart. 2010;96(20):1651–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Makki N, Capecchi MR. Cardiovascular defects in a mouse model of HOXA1 syndrome. Hum Mol Genet. 2012;21(1):26–31.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Donovan J, Kordylewska A, Jan YN, Utset MF. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol. 2002;12(18):1605–10.

    Article  CAS  PubMed  Google Scholar 

  37. Ishii M, Han J, Yen HY, Sucov HM, Chai Y, Maxson Jr RE. Combined deficiencies of Msx1 and Msx2 cause impaired patterning and survival of the cranial neural crest. Development. 2005;132(22):4937–50.

    Article  CAS  PubMed  Google Scholar 

  38. De Luca A, Sarkozy A, Ferese R, Consoli F, Lepri F, Dentici ML, Vergara P, De Zorzi A, Versacci P, Digilio MC, Marino B, Dallapiccola B. New mutations in ZFPM2/FOG2 gene in Tetralogy of Fallot and double outlet right ventricle. Clin Genet. 2011;80(2):184–90.

    Article  PubMed  Google Scholar 

  39. Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, Wilson DB, Watson MS, Hing AV. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet. 1999;83(3):201–6.

    Article  CAS  PubMed  Google Scholar 

  40. Watanabe Y, Miyagawa-Tomita S, Vincent SD, Kelly RG, Moon AM, Buckingham ME. Role of mesodermal FGF8 and FGF10 overlaps in the development of the arterial pole of the heart and pharyngeal arch arteries. Circ Res. 2010;106(3):495–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development. 2002;129(19):4613–25.

    CAS  PubMed  Google Scholar 

  42. Frank DU, Fotheringham LK, Brewer JA, Muglia LJ, Tristani-Firouzi M, Capecchi MR, Moon AM. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development. 2002;129(19):4591–603.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Park EJ, Ogden LA, Talbot A, Evans S, Cai CL, Black BL, Frank DU, Moon AM. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development. 2006;133(12):2419–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Beppu H, Malhotra R, Beppu Y, Lepore JJ, Parmacek MS, Bloch KD. BMP type II receptor regulates positioning of outflow tract and remodeling of atrioventricular cushion during cardiogenesis. Dev Biol. 2009;331(2):167–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, Spinner NB. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet. 2006;79(1):169–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development. 2002;129(4):1075–82.

    CAS  PubMed  Google Scholar 

  47. Martins P, Castela E. Transposition of the great arteries. Orphanet J Rare Dis. 2008;3:27.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Megarbane A, Salem N, Stephan E, Ashoush R, Lenoir D, Delague V, Kassab R, Loiselet J, Bouvagnet P. X-linked transposition of the great arteries and incomplete penetrance among males with a nonsense mutation in ZIC3. Eur J Hum Genet EJHG. 2000;8(9):704–8.

    Article  CAS  PubMed  Google Scholar 

  49. Gonzalez-Iriarte M, Carmona R, Perez-Pomares JM, Macias D, Costell M, Munoz-Chapuli R. Development of the coronary arteries in a murine model of transposition of great arteries. J Mol Cell Cardiol. 2003;35(7):795–802.

    Article  CAS  PubMed  Google Scholar 

  50. Kodo K, Nishizawa T, Furutani M, Arai S, Yamamura E, Joo K, Takahashi T, Matsuoka R, Yamagishi H. GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci U S A. 2009;106(33):13933–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Olaopa M, Zhou HM, Snider P, Wang J, Schwartz RJ, Moon AM, Conway SJ. Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation. Dev Biol. 2011;356(2):308–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Feiner L, Webber AL, Brown CB, Lu MM, Jia L, Feinstein P, Mombaerts P, Epstein JA, Raper JA. Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development. 2001;128(16):3061–70.

    CAS  PubMed  Google Scholar 

  53. Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013;112(4):707–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Work in the authors’ laboratory is supported by the Association Française contre les Myopathies (NMH-Decrypt Project), the Agence Nationale pour la Recherche (ANR-13-BSV2-0003-01), and the Institut National de la Santé et de la Recherche Médicale (S.Z.). B.L. received postdoctoral fellowship from the Fondation pour la Recherche Médicale (FRM) and the Agence Nationale pour la Recherche (ANR-13-BSV2-0003).

Author information

Authors and Affiliations

  1. Génétique Médicale & Génomique Fonctionnelle (GMGF), UMR_S910, Aix Marseille Université, Faculté de Médecine de la Timone, Marseille, 13005, France

    Brigitte Laforest PhD & Stéphane Zaffran PhD

  2. Inserm, U910, Marseille, 13005, France

    Brigitte Laforest PhD & Stéphane Zaffran PhD

  3. Medical Genetics & Functional Genomics, UMR_S910, Aix Marseille Université, Medical School of Marseille, Marseille, France

    Stéphane Zaffran PhD

  4. Laboratoire de Génétique Médicale et Génomique Fonctionnelle, Faculté de Médecin, 27 Bd Jean Moulin, Marseille, 13005, France

    Stéphane Zaffran PhD

Authors
  1. Brigitte Laforest PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stéphane Zaffran PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stéphane Zaffran PhD .

Editor information

Editors and Affiliations

  1. Royal Brompton Hospital, London, United Kingdom

    Francois Lacour-Gayet

  2. C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, Michigan, USA

    Edward L. Bove

  3. German Pediatric Heart Center, Asklepios Klinik Sankt Augustin Gmb, Sankt Augustin, Germany

    Viktor Hraška

  4. University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, USA

    Victor O. Morell

  5. Department of Cardiothoracic Surgery, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

    Thomas L. Spray

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Laforest, B., Zaffran, S. (2016). Genetics of Conotruncal Anomalies. In: Lacour-Gayet, F., Bove, E., Hraška, V., Morell, V., Spray, T. (eds) Surgery of Conotruncal Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-319-23057-3_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23057-3_36

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23056-6

  • Online ISBN: 978-3-319-23057-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation